A New Era of Cancer Care

Advances in science and technology have brought about a new wave of promising cancer…


Interview with Cheddar: Solving Unmet Need in Melanoma

I had the great privilege of speaking with Cheddar about the importance of cancer immunotherapy and…


Oncosec quarterly update

OncoSec Quarterly Update: July 2016

At OncoSec, we are committed to providing timely corporate updates, including recent achievements…


Dr. Holbrook Kohrt at DNA Vaccine Conference

Dr. Kohrt Adds Major Clout

Today I am proud to announce the appointment of Dr. Holbrook Kohrt to OncoSec’s Scientific Advisory…


2014 Annual Letter To OncoSec Shareholders

A Letter to Our Shareholders This is an important moment in cancer immunotherapy and we believe…


Building Relationships Between Biotech Corporations and Academia

I believe that integrating academic institutions with the research and development pipeline – and…